Clinical Study
Comparison of Short and Continuous Hydration Regimen in Chemotherapy Containing Intermediate- to High-Dose Cisplatin
Table 2
Demographics of the two groups.
| | | CH () | SH () | value |
| | Sex (male : female) | 11 : 6 | 10 : 3 | 0.46 | | Age (years) | | | 0.14 | | Height (cm) | | | 0.93 | | Weight (kg) | | | 0.20 | | BSA (m2) | | | 0.43 | | Type of disease | | | | | Gastric cancer | 14 | 5 | | | Urothelial cancer | 2 | 5 | | | Lung cancer | 1 | 3 | | | Combined with | | | | | TS-1 | 14 | 5 | | | Gemcitabine | 2 | 5 | | | Capecitabine | | 1 | | | Irinotecan | | 1 | | | Etoposide | 1 | 1 | | | Cr (mg/dL) | | | 0.32 | | CCr (mL/min) | | | 0.39 |
|
|
Values are mean ± SD.
CH: continuous hydration.
SH: short hydration.
BSA: body surface area.
Cr: creatinine.
CCr: creatinine clearance.
|
